Supplier
Pro Medquip
Pro Medquip was paid $746K by Medicaid between Nov 2020 and Nov 2024, across 24 billing codes. Its largest line is E0575, Nebulizer, ultrasonic, large volume — 19% of everything it billed.
33Billing provider infoPRO MEDQUIP
UNION CITY, NJ 07087
UNION CITY, NJ 07087
33aNPI1952617466assigned 08/20/2010
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$746K
24GClaims16,386
24DCodes billed24
24AFirst – last monthNov 2020 – Nov 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in New Jersey
Rank by total paid#42 of 302
Median peer was paid$689.07
This provider vs. median1,082×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 880 | $37K | |
| 2021 | 2,089 | $108K | |
| 2022 | 5,265 | $328K | |
| 2023 | 4,849 | $137K | |
| 2024incomplete | 3,303 | $134K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| E0575 | Nebulizer, ultrasonic, large volume | 19% | 560 | 479 | $139K |
| A9274 | External ambulatory insulin delivery system, disposable, each, includes all supplies and accessories | 16% | 55 | 49 | $118K |
| L3216 | Orthopedic footwear, ladies shoe, depth inlay, each | 12% | 2,206 | 863 | $90K |
| S8101 | Holding chamber or spacer for use with an inhaler or nebulizer; with mask | 9.9% | 1,895 | 1,734 | $74K |
| L2275 | Addition to lower extremity, varus/valgus correction, plastic modification, padded/lined | 7.9% | 1,418 | 541 | $59K |
| T4523 | Adult sized disposable incontinence product, brief/diaper, large, each | 6.6% | 1,226 | 524 | $49K |
| A4554 | Disposable underpads, all sizes | 4.7% | 2,237 | 1,011 | $35K |
| E0570 | Nebulizer, with compressor | 3.8% | 395 | 369 | $28K |
| L3020 | Foot, insert, removable, molded to patient model, longitudinal/ metatarsal support, each | 3.2% | 296 | 132 | $24K |
| E0784 | External ambulatory infusion pump, insulin | 3.0% | 21 | 15 | $22K |
| L3030 | Foot, insert, removable, formed to patient foot, each | 2.8% | 638 | 225 | $21K |
| L3217 | Orthopedic footwear, ladies shoe, hightop, depth inlay, each | 2.4% | 469 | 140 | $18K |
12 more codes
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | 2.3% | 2,254 | $17K |
| T4524 | Adult sized disposable incontinence product, brief/diaper, extra large, each | 1.8% | 324 | $13K |
| A6530 | Gradient compression stocking, below knee, 18-30 mmhg, each | 1.4% | 190 | $10K |
| S8100 | Holding chamber or spacer for use with an inhaler or nebulizer; without mask | 1.2% | 193 | $9K |
| L3001 | Foot, insert, removable, molded to patient model, spenco, each | <1% | 128 | $6K |
| L3221 | Orthopedic footwear, mens shoe, depth inlay, each | <1% | 152 | $6K |
| A5500 | For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe | <1% | 903 | $2K |
| L3010 | Foot, insert, removable, molded to patient model, longitudinal arch support, each | <1% | 24 | $2K |
| K0001 | Standard wheelchair | <1% | 165 | $2K |
| A5512 | For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each | <1% | 613 | $1K |
| E0143 | Walker, folding, wheeled, adjustable or fixed height | <1% | 12 | $142.10 |
| E0156 | Seat attachment, walker | <1% | 12 | $43.12 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFISHKIS, TATYANA (CEO)
| Provider | Location | Paid |
|---|---|---|
| Gramercy Drugs INC | Brooklyn, NY | $716K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.